Clin2
NCT06842186Possibly a fitRecruiting

Study of WVE-007 for overweight or obesity

Overweight and Obesity

Part of Hormones & metabolism clinical trials.

This trial tests an experimental drug called WVE-007 for people who are overweight or have obesity. It aims to help with weight loss and is looking at both a group without diabetes and a group with prediabetes or type 2 diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
296 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • Your weight is stable — you haven't gained or lost more than 5% in the last 3–6 months.
  • You are generally healthy, with no major heart, thyroid, or liver issues.
  • You are not currently taking prescription weight-loss meds, certain psychiatric meds, or more than 2 blood pressure or cholesterol medications.
  • You have not received an experimental drug or an siRNA agent in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06924320Recruiting· Phase 1/Phase 2
Study of two medicines for weight loss and diabetes

This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.

Cypress, California
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido
NCT07533175Recruiting· Phase 3
Testing a new weight-loss medicine for type 2 diabetes

This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.

Birmingham, Alabama
NCT06830343Recruiting· Phase 1
Safety study of SYH9017 for overweight and obesity

This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Beijing, Beijing Municipality
NCT07824804Not yet recruiting· Phase 1
Safety study of an injection for weight management

This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.

Kunming, Yunnan
NCT07725809Recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de

Hear when a new Overweight and Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.